Resistance to Ibritumomab in Lymphoma Resistance to Targeted Anti-Cancer Therapeutics, nr. 18 Editat de Makoto Hosono et al. 7 mai 2018 Hardback Preț: 703.86 lei 740.90 lei 6-8 săpt. -5%